A protein phosphatase network controls the temporal and spatial dynamics of differentiation commitment in human epidermis

Abstract

Epidermal homeostasis depends on a balance between stem cell renewal and terminal differentiation. The transition between the two cell states, termed commitment, is poorly understood. Here we characterise commitment by integrating transcriptomic and proteomic data from disaggregated primary human keratinocytes held in suspension to induce differentiation. Cell detachment induces several protein phosphatases, five of which - DUSP6, PPTC7, PTPN1, PTPN13 and PPP3CA - promote differentiation by negatively regulating ERK MAPK and positively regulating AP1 transcription factors. Conversely, DUSP10 expression antagonises commitment. The phosphatases form a dynamic network of transient positive and negative interactions that change over time, with DUSP6 predominating at commitment. Boolean network modelling identifies a mandatory switch between two stable states (stem and differentiated) via an unstable (committed) state. Phosphatase expression is also spatially regulated in vivo and in vitro. We conclude that an auto-regulatory phosphatase network maintains epidermal homeostasis by controlling the onset and duration of commitment.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Ajay Mishra

    Centre for Stem Cells and Regenerative Medicine, King's College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  2. Benedicte Oules

    Centre for Stem Cells and Regenerative Medicine, King's College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  3. Angela Oliveira Pisco

    Centre for Stem Cells and Regenerative Medicine, King's College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  4. Tony Ly

    Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom
    Competing interests
    No competing interests declared.
  5. Kifayathullah Liakath-Ali

    Centre for Stem Cells and Regenerative Medicine, King's College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  6. Gernot Walko

    Centre for Stem Cells and Regenerative Medicine, King's College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  7. Priyalakshmi Viswanathan

    Centre for Stem Cells and Regenerative Medicine, King's College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  8. Matthieu Tihy

    Centre for Stem Cells and Regenerative Medicine, King's College London, London, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9314-4657
  9. Jagdeesh Nijjher

    Centre for Stem Cells and Regenerative Medicine, King's College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  10. Sara-Jane Dunn

    Microsoft Research, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
  11. Angus I Lamond

    Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6204-6045
  12. Fiona M Watt

    Centre for Stem Cells and Regenerative Medicine, King's College London, London, United Kingdom
    For correspondence
    fiona.watt@kcl.ac.uk
    Competing interests
    Fiona M Watt, Deputy editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9151-5154

Funding

Wellcome Trust (096540/Z/11/Z)

  • Benedicte Oules
  • Kifayathullah Liakath-Ali
  • Gernot Walko
  • Priyalakshmi Viswanathan
  • Jagdeesh Nijjher
  • Sara-Jane Dunn
  • Angus I Lamond
  • Fiona M Watt

Medical Research Council (G1100073)

  • Angela Oliveira Pisco

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Valerie Horsley, Yale University, United States

Version history

  1. Received: April 1, 2017
  2. Accepted: October 10, 2017
  3. Accepted Manuscript published: October 18, 2017 (version 1)
  4. Version of Record published: November 2, 2017 (version 2)

Copyright

© 2017, Mishra et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,375
    Page views
  • 678
    Downloads
  • 38
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ajay Mishra
  2. Benedicte Oules
  3. Angela Oliveira Pisco
  4. Tony Ly
  5. Kifayathullah Liakath-Ali
  6. Gernot Walko
  7. Priyalakshmi Viswanathan
  8. Matthieu Tihy
  9. Jagdeesh Nijjher
  10. Sara-Jane Dunn
  11. Angus I Lamond
  12. Fiona M Watt
(2017)
A protein phosphatase network controls the temporal and spatial dynamics of differentiation commitment in human epidermis
eLife 6:e27356.
https://doi.org/10.7554/eLife.27356

Share this article

https://doi.org/10.7554/eLife.27356

Further reading

    1. Cell Biology
    2. Computational and Systems Biology
    Thomas Grandits, Christoph M Augustin ... Alexander Jung
    Research Article

    Computer models of the human ventricular cardiomyocyte action potential (AP) have reached a level of detail and maturity that has led to an increasing number of applications in the pharmaceutical sector. However, interfacing the models with experimental data can become a significant computational burden. To mitigate the computational burden, the present study introduces a neural network (NN) that emulates the AP for given maximum conductances of selected ion channels, pumps, and exchangers. Its applicability in pharmacological studies was tested on synthetic and experimental data. The NN emulator potentially enables massive speed-ups compared to regular simulations and the forward problem (find drugged AP for pharmacological parameters defined as scaling factors of control maximum conductances) on synthetic data could be solved with average root-mean-square errors (RMSE) of 0.47 mV in normal APs and of 14.5 mV in abnormal APs exhibiting early afterdepolarizations (72.5% of the emulated APs were alining with the abnormality, and the substantial majority of the remaining APs demonstrated pronounced proximity). This demonstrates not only very fast and mostly very accurate AP emulations but also the capability of accounting for discontinuities, a major advantage over existing emulation strategies. Furthermore, the inverse problem (find pharmacological parameters for control and drugged APs through optimization) on synthetic data could be solved with high accuracy shown by a maximum RMSE of 0.22 in the estimated pharmacological parameters. However, notable mismatches were observed between pharmacological parameters estimated from experimental data and distributions obtained from the Comprehensive in vitro Proarrhythmia Assay initiative. This reveals larger inaccuracies which can be attributed particularly to the fact that small tissue preparations were studied while the emulator was trained on single cardiomyocyte data. Overall, our study highlights the potential of NN emulators as powerful tool for an increased efficiency in future quantitative systems pharmacology studies.

    1. Computational and Systems Biology
    2. Neuroscience
    Domingos Leite de Castro, Miguel Aroso ... Paulo Aguiar
    Research Article Updated

    Closed-loop neuronal stimulation has a strong therapeutic potential for neurological disorders such as Parkinson’s disease. However, at the moment, standard stimulation protocols rely on continuous open-loop stimulation and the design of adaptive controllers is an active field of research. Delayed feedback control (DFC), a popular method used to control chaotic systems, has been proposed as a closed-loop technique for desynchronisation of neuronal populations but, so far, was only tested in computational studies. We implement DFC for the first time in neuronal populations and access its efficacy in disrupting unwanted neuronal oscillations. To analyse in detail the performance of this activity control algorithm, we used specialised in vitro platforms with high spatiotemporal monitoring/stimulating capabilities. We show that the conventional DFC in fact worsens the neuronal population oscillatory behaviour, which was never reported before. Conversely, we present an improved control algorithm, adaptive DFC (aDFC), which monitors the ongoing oscillation periodicity and self-tunes accordingly. aDFC effectively disrupts collective neuronal oscillations restoring a more physiological state. Overall, these results support aDFC as a better candidate for therapeutic closed-loop brain stimulation.